Risk Factors for the Occurrence of Post Intensive Care Syndrome (PICS)
NCT ID: NCT05534828
Last Updated: 2024-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
97 participants
OBSERVATIONAL
2022-10-10
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19
NCT04619368
Incidence and Factors Associated to the Development of PICS-F Among ICU Relatives: A Longitudinal Exploratory Study
NCT05827354
Long-term Follow up in Survivors of Critical Illness
NCT04608994
ICU Follow-up After Prolonged Intensive Care Stay
NCT04186468
User Experience of a Telemedicine Platform for the Follow-up of Post Intensive Care Syndrome (PICS)
NCT06438380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This consultation is scheduled and will take place approximately three months after the end of the stay in the intensive care unit.
During this consultation, signs will be sought through questioning to detect or even diagnose the presence of a PICS.
We will also look for elements that will allow us to characterize people with CHIP.
If a PICS was detected during the consultation, the summary letter sent to the attending physician informs him/her of
1. The presence of a CHIP in his patient
2. The nature of this CHIP (CHIP with a purely psychological component, CHIP with a psychological and physical component, etc.) In this same summary letter, the attending physician will be offered a list of specialists practicing at the CHU who are likely to take charge of the patient's CHIP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A consultation
A consultation at three months of discharge from the intensive care unit in the population of patients surviving a multivalent intensive care unit stay
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized in the intensive care unit of Rangueil of the TOULOUSE University Hospital
* length of stay in intensive care equal or superior to 24 hours
* affiliated to a social security system
* having expressed no objection to participate in the study
Exclusion Criteria
* no consent to the study
* patient not capable of expressing his "non opposition" to the study
* patient under guardianship, curatorship or safeguard of justice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A01371-42
Identifier Type: OTHER
Identifier Source: secondary_id
RC31/22/0215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.